Can allogeneic stem cells improve outcomes after stroke?
- PMID: 28320634
- PMCID: PMC5739028
- DOI: 10.1016/S1474-4422(17)30075-3
Can allogeneic stem cells improve outcomes after stroke?
Comment on
-
Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.Lancet Neurol. 2017 May;16(5):369-376. doi: 10.1016/S1474-4422(17)30047-9. Epub 2017 Mar 16. Lancet Neurol. 2017. PMID: 28318984 Clinical Trial.
References
-
- Winstein CJ, Stein J, Arena R, et al. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016;47(6):e98–e169. - PubMed
-
- Hess DCWL, Clark WM, Savitz SI, Ford GA, Chiu D, Yavagal DR, Uchino K, Liebeskind DS, Auchus AP, Sen S, Sila CA, Vest JD, Mays RW. Safety and efficacy of multipotent adult progenitor cellsin acute ischaemic stroke (MASTERS): a randomized, doubleblind, placebo-controlled phase 2 trial. Lancet Neurology. 2017;XXX:XXX–XXX. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical